New Zealand markets close in 6 hours 50 minutes

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
193.18-0.93 (-0.48%)
At close: 04:00PM EDT
193.20 +0.02 (+0.01%)
After hours: 06:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 28.23B
Enterprise value 34.52B
Trailing P/E 24.37
Forward P/E 12.66
PEG ratio (5-yr expected) 6.24
Price/sales (ttm)2.88
Price/book (mrq)1.91
Enterprise value/revenue 3.51
Enterprise value/EBITDA 16.93

Trading information

Stock price history

Beta (5Y monthly) -0.01
52-week change 3-31.27%
S&P500 52-week change 323.06%
52-week high 3319.76
52-week low 3189.44
50-day moving average 3215.24
200-day moving average 3244.85

Share statistics

Avg vol (3-month) 31.19M
Avg vol (10-day) 31.17M
Shares outstanding 5145.36M
Implied shares outstanding 6145.36M
Float 8144.82M
% held by insiders 10.69%
% held by institutions 193.01%
Shares short (28 Mar 2024) 43.55M
Short ratio (28 Mar 2024) 42.66
Short % of float (28 Mar 2024) 42.76%
Short % of shares outstanding (28 Mar 2024) 42.44%
Shares short (prior month 29 Feb 2024) 42.8M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 318 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 11.81%
Operating margin (ttm)19.32%

Management effectiveness

Return on assets (ttm)4.58%
Return on equity (ttm)8.24%

Income statement

Revenue (ttm)9.84B
Revenue per share (ttm)67.97
Quarterly revenue growth (yoy)-6.20%
Gross profit (ttm)N/A
Net income avi to common (ttm)1.16B
Diluted EPS (ttm)7.96
Quarterly earnings growth (yoy)-54.60%

Balance sheet

Total cash (mrq)1.05B
Total cash per share (mrq)7.22
Total debt (mrq)7.43B
Total debt/equity (mrq)50.20%
Current ratio (mrq)2.00
Book value per share (mrq)102.14

Cash flow statement

Operating cash flow (ttm)1.55B
Levered free cash flow (ttm)971.06M